Altered drug metabolism and increased susceptibility to fatty liver disease in a mouse model of myotonic dystrophy
Abstract Myotonic Dystrophy type 1 (DM1), a highly prevalent form of muscular dystrophy, is caused by (CTG)n repeat expansion in the DMPK gene. Much of DM1 research has focused on the effects within the muscle and neurological tissues; however, DM1 patients also suffer from various metabolic and liv...
Saved in:
| Main Authors: | Zachary Dewald, Oluwafolajimi Adesanya, Haneui Bae, Andrew Gupta, Jessica M. Derham, Ullas V. Chembazhi, Auinash Kalsotra |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-10-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-53378-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ophthalmological findings in myotonic dystrophy
by: Maddalena De Bernardo, et al. -
MRI in Congenital Myotonic Dystrophy
by: J Gordon Millichap
Published: (1992-10-01) -
Cardiac manifestations in myotonic dystrophy type 1
by: A. G. Klementieva, et al.
Published: (2024-09-01) -
Concurrent Myotonic Dystrophy and Inflammatory Myopathy in a Patient with HIV/AIDS
by: Akash Gupta, et al.
Published: (2021-01-01) -
Myotonic dystrophy type 1: frequency of ophthalmologic findings
by: Karin Suzete Ikeda, et al.
Published: (2016-03-01)